![Chemical structure of 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione, CAS 24584-09-6](https://api.angenesci.com/structure/4000/24584-09-6.png)
无数据
无数据
无数据
| CAS Number | 24584-09-6 |
| Catalog Number | AG002ONZ(AGN-PC-0O877E) |
| Chemical Name | 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione |
| IUPAC Name | 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione |
| InChI | InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)/t7-/m0/s1 |
| InChI Key | BMKDZUISNHGIBY-ZETCQYMHSA-N |
| MDL Number | MFCD00866449 |
| Molecular Formula | C11H16N4O4 |
| Molecular Weight | 268.2691 |
| NSC Number | 169780 |
| SMILES | C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1 |
| UNII | 048L81261F |
| Synonyms | ADR 529,
ADR-529,
ADR529,
Cardioxan,
Cardioxane,
Dexrazoxane,
Dexrazoxane Hydrochloride,
Hydrochloride, Dexrazoxane,
ICRF 187,
ICRF-187,
ICRF187,
NSC 169780,
NSC-169780,
NSC169780,
Razoxane, (S)-Isomer,
Razoxane, (S)-Isomer, Hydrochloride,
Zinecard,
Dexrazoxane,
24584-09-6,
Zinecard,
(S)-4,4'-(Propane-1,2-diyl)bis(piperazine-2,6-dione),
Cardioxane,
ICRF-187,
Dexrazoxano,
Dexrazoxanum,
Dextrorazoxane,
Dexrazoxanum [INN-Latin],
Dexrazoxano [INN-Spanish],
Desrazoxane,
Eucardion,
ADR 529,
ICRF 187,
(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione,
Dexrazone,
ADR-529,
(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane,
HSDB 7319,
UNII-048L81261F,
NSC169780,
BRN 5759131,
dyzoxane,
CHEBI:50223,
4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione,
NSC 169780,
MFCD00866449,
Razoxanum [INN-Latin],
Razoxana [INN-Spanish],
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+)-,
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (S)-,
2,6-Piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-,
048L81261F,
4-[(2S)-1-(3,5-dioxopiperazin-1-yl)propan-2-yl]piperazine-2,6-dione,
(S)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane,
DSSTox_CID_20647,
DSSTox_RID_79520,
2,6-Piperazinedione, 4,4'-propylenedi-, (+)-,
DSSTox_GSID_40647,
(+)-dexrazoxane,
C11H16N4O4,
Razoxane, (S)-Isomer,
NSC-169780,
CAS-24584-09-6,
Dexrazoxane [USAN:BAN:INN],
SR-01000883995,
Soluble ICRF (L-isosomer),
Dexrazoxan,
Dexrazoxane [USAN:INN:BAN],
CCRIS 9394,
(S)-4,4'-(1-METHYL-1,2-ETHANEDIYL)BIS-2,6-PIPERAZINEDIONE,
NCGC00164737-01,
AK-72797,
AC1Q6LVI,
CHEMBL1738,
Dexrazoxane ((S)-Razoxane),
SCHEMBL18400,
MLS006010158,
BIDD:GT0068,
Dexrazoxane (JAN/USAN/INN),
(S)-(+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane,
4,4'-(2S)-propane-1,2-diyldipiperazine-2,6-dione,
AC1L2G28,
GTPL7330,
DTXSID3040647,
CTK8B4408,
Dexrazoxane, >=95% (HPLC),
EBD45155,
HY-B0581,
KS-00000G0G,
Tox21_112256,
2, 4,4'-propylenedi-, (+)-,
ANW-44923,
ZINC87515509,
AKOS015896392,
Tox21_112256_1,
(+)-1,5-dioxopiperazin-1-yl)propane,
API0006306,
CS-2769,
DB00380,
DS-1394,
MP-0159,
RP29555,
NCGC00263544-01,
NCGC00263544-02,
AJ-79327,
AN-14921,
BR-72797,
CC-26376,
Dexrazoxane, analytical reference material,
NCI60_001367,
SMR002529680,
AB0011515,
AX8123889,
LS-111911,
TR-011328,
(S)-(+)-1,5-dioxopiperazin-1-yl)propane,
D4227,
FT-0653845,
ST24026597,
D03730,
J90038,
AB01273932-01,
AB01273932-02,
AB01273932_03,
2,4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-,
584D096,
A817380,
C-23732,
2,4,4'-(1-methyl-1,2-ethanediyl)bis-, (S)-,
I06-1989,
J-015579,
J-520219,
SR-01000883995-1,
SR-01000883995-2,
SR-01000883995-5,
(S)-4,4'-(propane-1,2-diyl)dipiperazine-2,6-dione,
BRD-K07265709-003-01-5,
(S)-4,4-(Propane-1,2-diyl)bis(piperazine-2,6-dione),
4,4'-[(2S)-1,2-Propanediyl]di(2,6-piperazinedione),
(S)-4,4'-(Propane-1,2-diyl)-bis(piperazine-2,6-dione),
UNII-5AR83PR647 component BMKDZUISNHGIBY-ZETCQYMHSA-N,
4-[(2S)-2-(3,5-dioxo-1-piperazinyl)propyl]piperazine-2,6-dione,
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+)- (9CI),
4-[(2S)-2-[3,5-bis(oxidanylidene)piperazin-1-yl]propyl]piperazine-2,6-dione,
6-hydroxy-4-[(2S)-2-(5-hydroxy-3-oxo-1,2,3,6-tetrahydropyrazin-1-yl)propyl]-2,3,4,5-tetrahydropyrazin-2-one,
Savene,
Totect,
Dexrazoxane HCl,
Cardioxan,
Razoxane,
Tepirone,
Troxozone,
Razoxin,
TopoTect,
Cardioxane (TN),
Dexrazoxane (TN),
Dexrazoxane hydrochloride,
Zinecard (TN),
Totect (TN),
ICRF 187 hydrochloride,
Dexrazoxane (USAN/INN),
Hydrochloride, Dexrazoxane,
D07XVN,
D0X3ST,
ICRF187,
ADR529,
CID71384,
Razoxane, (S)-Isomer, Hydrochloride,
C11-H16-N4-O4,
Dexrazoxane HCl (ICRF-187, ADR-529),
3082B,
A1602,
(+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane,
D064730,
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, ()-,
Totect, ICRF-187, Zinecard, Cardioxane, Dexrazoxane Hydrochloride,
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+)-(9CI),
4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione hydrochloride,
149003-01-0,
CDX,
|
| Complexity | 404 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 268.117g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 19 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 268.273g/mol |
| Monoisotopic Mass | 268.117g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 98.8A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -1.4 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H315-H319-H335 |
| Packing Group | Ⅲ |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

